; or (II) adverse impacts on the environment; and (ii) satisfies 1 or more of the conditions described in subparagraph (B). (B) Conditions The conditions referred to in subparagraph (A)(ii) are the following: (i) The substance, mixture, or compound is subject to reporting requirements under— (I) the Emergency Planning and Community Right-To-Know Act of 1986 ( 42 U.S.C. 11001 et seq. ); (II) the Comprehensive Environmental Response, Compensation, and Liability Act of 1980 ( 42 U.S.C. 9601 et seq. ); or (III) section 112(r) of the Clean Air Act ( 42 U.S.C. 7412(r) ). (ii) The National Institute for Occupational Safety and Health, the Occupational Safety and Health Administration, the National Toxicology Program, the Centers for Disease Control and Prevention, the Administrator of Health and Human Services, the National Institute for Environmental Health Sciences, or the Environmental Protection Agency has established that the substance, mixture, or compound poses an acute or chronic health hazard, including developmental, reproductive, or endocrine effects. (iii) The National Institute for Occupational Safety and Health or the Environmental Protection Agency has recognized that the substance, mixture, or compound may increase the risk of developing a latent disease. (iv) The substance, mixture, or compound is— (I) a perfluoroalkyl or polyfluoroalkyl substance; (II) an orthophthalate; (III) a bisphenol compound (but not including an alkyl-substituted bisphenol compound generated through a xylenol-aldehyde process); (IV) a halogenated or nanoscale flame-retardant chemical; (V) UV 328 (2-(2H-benzotriazol-2-yl)-4,6-di-tert-pentylphenol); (VI) a chlorinated paraffin; (VII) listed as a persistent organic pollutant by the Stockholm Convention on Persistent Organic Pollutants; (VIII) given an overall carcinogenicity evaluation of Group 1, Group 2A, or Group 2B by the International Agency for Research on Cancer